While the shooting star Lagevrio pushed Merck’s top line to nearly $60 billion in 2022, the rest of the company’s portfolio is catching up.
Tag Archive for: Vaccines
Johnson & Johnson appears to be winding down research at its infectious disease and vaccine unit, save for a few select programs, according to Fierce Biotech on Wednesday, citing sources familiar with the matter.
In a less-than-shocking development, the top drugs of the launch class of 2021 were all for preventing or treating everyone’s least favorite virus.
Pfizer will launch a cost-cutting program if demand for its COVID-19 products keeps underperforming expectations this fall, the U.S. drugmaker said on Tuesday, after quarterly sales for the vaccine and pill fell short of Wall Street targets.
The European Commission has contracted pharma companies including Pfizer to reserve capacity to make up to 325 million vaccines per year in case of a future global health emergency.
Promosome filed lawsuits Tuesday against Moderna and Pfizer/BioNTech, alleging that the vaccine developers used patent-protected mRNA technology without a license.
The contract manufacturer has been facing challenges at three of its major production sites, which may affect its third and fourth-quarter revenue due to a slower-than-expected ramp up in production capacity.
Executives at three vaccine manufacturers – GSK, Moderna, and CSL Seqirus told Reuters they are already developing or about to test sample human vaccines that better match the circulating subtype, as a precautionary measure against a future pandemic.
Governments should invest in vaccines for all strains of influenza virus that exist in the animal kingdom as an insurance policy in case of an outbreak in humans, the incoming chief scientist at the World Health Organization said on Monday.
The extension allows millions of Americans to continue receiving free tests, vaccines, and treatments.
